Search results
When will Novavax's vaccine be available, and how can I get it?
CBS News via Yahoo News· 2 years agoThe Biden administration is warning states to prepare for a "limited supply" of Novavax's COVID-19...
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 6 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 weeks agoFor Immediate Release Chicago, IL – May 17, 2024 – Zacks.com announces the list of stocks featured...
Novavax (NVAX) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoWe expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19...
FDA could green light new Covid boosters as early as Friday
NBC News via Yahoo News· 9 months agoThe Food and Drug Administration plans to greenlight updated versions of the Covid boosters as early...
Scared of Omicron BA.4/BA.5? Novavax Has a Vaccine for That
TipRanks via Yahoo Finance· 2 years agoOn Tuesday afternoon, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological...
Novavax has its sights set on the commercial COVID-19 vaccine market
Yahoo Finance via AOL· 2 years agoNovavax isn't swayed by the negative perceptions and delays in reaching the. market in the U.S., and...
New COVID-19 Vaccines Should Protect Against BA.2.86 and EG.5, Early Research Shows
Verywell Health via Yahoo News· 9 months agoUpdated versions of COVID vaccines from Pfizer and Moderna earned FDA approval on Monday. While...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 6 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 1 week ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...